Do Calming Treats Actually Work for Dogs?

Some ingredients have evidence, most don't, and the placebo effect in owner-reported studies is real. An honest look at what calming treats can and can't do.

Published

Apr 8, 2026

Updated

Apr 8, 2026

References

5 selected

This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.

Why the honest answer is “it depends”

“Calming treat” is a marketing category, not a regulatory one. The FDA does not recognize a class of pet products called calming treats. What you find on the shelf is a mix of soft chews containing anywhere from one to eight active ingredients, with wildly different formulations, doses, and quality standards — all sharing the same label language.

Some of those ingredients have peer-reviewed canine studies behind them. Others are borrowed from human herbal medicine with no controlled dog data at all. A few have been tested in specific commercial formulations that performed well in randomized trials — but that result applies to that product at that dose, not to every treat containing the same ingredient name on the back of the bag.

So the question isn’t really “do calming treats work?” It’s “does this specific ingredient, at this dose, in this product, address your dog’s specific anxiety pattern?” That narrower question has a more useful answer.

Key takeaway

“Calming treat” is a shelf label, not an evidence category. Whether a product works depends on the ingredient, the dose, and the dog.

The placebo problem in pet supplement research

Here is something the calming treat industry would prefer you didn’t think about: in most pet supplement studies, the person evaluating whether the dog got better is the owner. And owners who believe their dog received a treatment tend to report improvement — even when their dog got the placebo.

A 2021 double-blind, placebo-controlled trial (PMCID: PMC8464231) testing a fish-hydrolysate calming supplement found real differences between the supplement and placebo groups in some behavioral measures. But it also found that owners in both groups reported behavioral changes during the study. The placebo group didn’t stay flat — owners who thought their dog might be getting help saw improvement regardless.

This is not unique to that study. It’s a known pattern in veterinary behavioral research: owner expectations shape owner reports. When the only way to measure “did the dog get calmer?” is to ask the person who bought the product and wants it to work, you get noisy data.

That doesn’t mean calming treats are worthless. It means that the bar for claiming one “works” is higher than a collection of five-star reviews. The studies that matter most use objective measures — cortisol levels, coded video analysis by blinded observers, physiological biomarkers — alongside owner questionnaires. When both the objective and subjective measures move in the same direction, the signal is stronger.

Key takeaway

Owner-reported improvement is not the same as objective evidence. The strongest studies use cortisol, video coding, or biomarkers alongside owner questionnaires. Reviews on Amazon are not data.

Not sure which ingredient type fits your dog’s pattern? Walk through it with Scout — Scout will ask about triggers, timing, and what you’ve already tried before recommending anything.

Ingredient evidence tiers: strong, moderate, weak, and absent

Not all calming ingredients are created equal. Here is how the evidence stacks up, based on published canine-specific research — not extrapolations from rodent models or human herbal tradition. For a deeper dive into overall supplement evidence, see our calming supplements guide.

Moderate evidence: Alpha-casozepine

Best canine-specific data among common calming treat ingredients.

Alpha-casozepine is a decapeptide derived from bovine milk protein. It binds to GABA-A receptors and can cross the blood-brain barrier. Published multi-center blinded studies have found alpha-casozepine performed comparably to selegiline (a prescription medication) on owner-reported emotional disorder scores. A separate blinded trial reported that anxious dogs on an alpha-casozepine diet for 65 days showed improvement in both behavioral measures and cortisol levels. These findings are reviewed in a 2022 dietary strategies review (PMCID: PMC10045725). You’ll find alpha-casozepine in products marketed under the Zylkene brand name and in some combination formulas. The caveat: most studies tested specific proprietary formulations, not generic alpha-casozepine from any source.

Moderate evidence: L-theanine

Reasonable canine data, but results are mixed across studies.

L-theanine is an amino acid from green tea that modulates glutamate receptors and influences GABA activity. Several canine studies have tested it — some in combination products like VetriScience Composure (which pairs L-theanine with colostrum and thiamine). Results have been mixed: some trials show reduced anxiety scores, others show no significant effect. The pattern suggests L-theanine may help some dogs in some contexts, but it is not a reliable standalone anxiolytic.

Moderate evidence: Specific probiotic strains

Mechanism is plausible. Dog-specific behavioral data is still early.

The gut-brain axis is real, and a 2024 review (PMCID: PMC10827376) describes the bidirectional signaling pathways — vagal nerve, microbial metabolites, HPA axis regulation — that connect the gut microbiome to mood and behavior in dogs. A randomized trial of Lactiplantibacillus plantarum LP815 found that supplemented dogs showed reduced activity levels post-departure compared to placebo, suggesting improved calmness. But the field is young. Most probiotic-anxiety studies in dogs have small sample sizes, and specific strain matters: “probiotics” as a generic category tells you very little.

Limited evidence: CBD

Most canine CBD data is from pain studies, not anxiety.

CBD gets enormous attention, but its canine anxiety evidence is thinner than most people assume. The bulk of peer-reviewed canine CBD research (PMCID: PMC10347378) comes from osteoarthritis and pain models. A 2025 crossover study (PMCID: PMC12339541) tested a treat combining CBD with L-tryptophan and alpha-casozepine during car-travel stress: cortisol reduction reached significance, but most behavioral outcome measures did not. Individual variability in CBD bioavailability was high, making it hard to generalize across products. For a full breakdown, see our CBD for dogs guide.

Weak or absent evidence: Chamomile, valerian, passionflower

Popular in products. Essentially untested in dogs.

These botanicals appear on the ingredient panel of dozens of calming treats. They have long histories in human herbal medicine and some show GABAergic or serotonergic activity in lab dishes or rodent models. But controlled studies in dogs? Almost none. When you see chamomile or passionflower on a calming chew label, you are trusting a cross-species extrapolation, not canine evidence. That doesn’t mean these ingredients are harmful — they are generally considered safe — but the honest answer is: we don’t know if they calm dogs, because nobody has properly tested it.

Weak evidence: Melatonin

Widely recommended. Canine anxiety data is surprisingly thin.

Melatonin is one of the most commonly recommended calming supplements for dogs, especially for noise phobias. Vets prescribe it regularly. But the canine behavioral evidence is largely based on clinical experience and extrapolation from mammalian circadian research — not from controlled anxiolysis trials in dogs. It may help some dogs in some situations, and it has a favorable safety profile at appropriate doses, but the gap between how often it is recommended and how well it has been studied in dogs is wider than most owners realize.

Key takeaway

Alpha-casozepine and L-theanine have the strongest canine data among calming treat ingredients. CBD’s anxiety evidence is thinner than its marketing. Chamomile, valerian, and passionflower are essentially untested in dogs.

What to look for on the label (and what to avoid)

The difference between a calming treat that might help and one that is mostly marketing comes down to a few things you can check before buying. None of these guarantee the product will work for your dog — but they filter out the products that almost certainly won’t.

  1. Individual ingredient amounts, not “proprietary blends.” If the label lists a blend weight without breaking down how much of each ingredient is in it, you cannot evaluate whether your dog is getting a meaningful dose of anything. A 500mg “Calming Blend” could be 490mg filler and 10mg of the ingredient you actually care about. Products like VetriScience Composure list individual amounts per chew — that transparency is the minimum standard.
  2. Weight-based dosing. A 12-pound Chihuahua and a 90-pound Lab should not take the same dose. Metabolic rate, liver clearance, and volume of distribution scale with body weight. Products that provide a dosing chart by weight range — like PetHonesty Calming Chews and Zesty Paws Calming Bites — allow for more precise dosing than a flat “one chew per day” instruction.
  3. NASC Quality Seal. Look for brands that carry NASC membership and follow Good Manufacturing Practices, label accurately, and participates in adverse event reporting. It does not prove the product works — but in an industry with minimal federal oversight (PMCID: PMC7802882), it is the best quality floor available.
  4. Third-party testing for CBD products. If the product contains CBD, look for a current Certificate of Analysis (COA) from an independent lab. The COA confirms that the cannabinoid content matches the label and screens for contaminants. Any CBD manufacturer that does not publish COAs is not transparent enough to trust. For the full breakdown on CBD quality, see our hemp vs CBD guide.
  5. No cure or treatment claims. Calming treats are not drugs. If a product says it “treats,” “cures,” or “eliminates” anxiety, it is making a drug claim that the FDA has not approved and that the evidence does not support. The honest framing is “may support calm behavior” — anything stronger is marketing overreach.

Key takeaway

Transparent dosing, individual ingredient amounts, NASC seal, and honest claims. These do not guarantee the treat works, but they filter out the ones that are mostly packaging.

When calming treats are worth trying — and when they are not enough

Calming treats fit a specific niche. They are not the first line of defense and they are not a substitute for behavior work — but they are not snake oil either. The question is whether your dog’s situation matches what these products can reasonably do.

Reasonable to try

Mild to moderate anxiety with identifiable triggers. Situational stress — vet visits, car rides, a visiting houseguest — where you can dose 30-60 minutes before the event. As a supplement to an existing behavioral plan, not as a replacement for one. When you have already addressed the environmental basics: exercise, routine, safe spaces, and trigger management. When you choose a product with transparent dosing and at least one evidence-backed ingredient.

Probably not enough

Severe separation anxiety that involves destruction, self-injury, or escape attempts. Aggression — whether fear-based or otherwise. Anxiety that has not responded to environmental changes and consistent behavior modification over several weeks. Panic-level reactions to noise where the dog is at risk of hurting themselves. Any situation where your vet has already discussed behavioral medication. In those cases, a calming treat is not the right tool. A veterinary behaviorist and potentially prescription medication are where the evidence points.

The gap between “reasonable to try” and “not enough” is where most owners get stuck. If you are unsure which side your dog falls on, that uncertainty is itself a reason to talk to your vet — not to buy another product and hope for the best.

Key takeaway

Calming treats fit best as a supporting layer for mild to moderate, trigger-specific anxiety. For severe or treatment-resistant anxiety, they are not a substitute for professional help.

Frequently asked questions

Do calming treats actually work for dogs?

It depends on the ingredient and the product. A few active compounds — alpha-casozepine, L-theanine, and specific probiotic strains — have peer-reviewed canine data suggesting mild calming effects. Many popular ingredients like chamomile and passionflower lack controlled dog studies entirely. Owner-reported improvements in placebo-controlled trials often appear in both groups, which means some perceived benefit may reflect the owner’s expectations rather than the treat itself.

What calming treat ingredient has the most evidence?

Among ingredients commonly found in calming treats, alpha-casozepine has the strongest canine-specific data. A multi-center blinded study found it performed comparably to selegiline on owner-reported emotional disorder scores, and a separate blinded trial showed behavioral and cortisol improvement after 65 days. L-theanine has moderate evidence but with more mixed results across studies.

How do I know if a calming treat is working?

Track specific behaviors, not your general impression. Before starting the treat, write down 2-3 observable anxiety signs: panting frequency during triggers, time to settle after a stressor, number of barking episodes per day. Measure those same signs after 2-4 weeks. If you rely only on gut feeling, you are vulnerable to the same expectation bias that complicates clinical trials. A structured approach gives you a real answer.

Evidence-informed guide

Pawsd guides are educational and not a substitute for veterinary advice. These pages draw from selected open-access peer-reviewed veterinary research, with full-text sources linked below.

Selected references

Effects of a new dietary supplement on behavioural responses of dogs exposed to mild stressors.

Vet Rec Open. 2021;8(1):e22. PMCID: PMC8464231. Double-blind placebo-controlled RCT testing a fish-hydrolysate supplement in dogs under mild stress; showed supplement effect on behavior but also revealed placebo-group improvements.

Effects of a Nutritional Supplement (DiRelax) on Anxiety in Dogs in a Randomized Control Trial Design.

Animals (Basel). 2022;12(4):435. PMCID: PMC8868118. Randomized controlled trial of a multi-ingredient nutraceutical for canine anxiety.

Treats containing cannabidiol, L-tryptophan and alpha-casozepine have a mild stress-reducing effect in dogs.

Front Vet Sci. 2025;12:1632868. PMCID: PMC12339541. Crossover study of a CBD-plus-amino-acid treat; cortisol reduction reached significance but most behavioral measures did not.

Gut-Brain Axis Impact on Canine Anxiety Disorders: New Challenges for Behavioral Veterinary Medicine.

Vet Med Int. 2024;2024:2856759. PMCID: PMC10827376. Review of microbiome-gut-brain signaling pathways relevant to canine anxiety.

Veterinary Pet Supplements and Nutraceuticals.

Vet Sci. 2021;8(1):4. PMCID: PMC7802882. Overview of supplement regulation, evidence standards, and quality control in the pet nutraceutical market.

The right answer depends on your dog.

Tell Scout about your dog's anxiety pattern, triggers, and what you've already tried. Scout will recommend specific ingredients — not a generic calming treat — based on what's actually going on.

Talk to Scout about your dog

Related Reading

This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.